These findings of galangin inhibiting the thrombin-induced MMP-9 expression in SK-N-SH cells indicate that galangin might be a potential candidate for the therapeutic agents of brain inflammatory and degenerative diseases. Here, MMP9 is linked to neurodegenerative disease.